-
Science & Medicine: Revolutionizing prostate cancer treatment
28 Apr 2024 12:19 GMT
… how we approach men with prostate cancer, balancing disease control and quality … questions like, "does every prostate cancer patient need androgen deprivation therapy … radiation techniques like stereotactic body radiation therapy, which is so powerful and …
-
Astellas’ XTANDI (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
25 Apr 2024 19:27 GMT
… with or without ADT, after radiation therapy or surgery. Up until now … living with advanced prostate cancer. Many men with hormone-sensitive prostate cancer undergo arduous … Use in Additional Recurrent Early Prostate Cancer Treatment Setting [Press release]. …
-
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up.
25 Apr 2024 07:49 GMT
… local recurrence after primary curative radiation therapy for prostate cancer (PCa), as prospective … toxicity was scored according to Radiation Therapy Oncology Group criteria.
Median … PCa after primary curative radiation therapy is clinically feasible and …
-
Hemorrhagic cystitis could occur in prostate cancer patients 1 year after radiotherapy. Why?
25 Apr 2024 07:07 GMT
… occur after radiation therapy for prostate cancer.
The basic principle of radiation therapy is to …
Radiation therapy for prostate cancer is indicated for localized prostate cancer, locally progressive prostate cancer, and locally recurrent prostate cancer …
-
EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
25 Apr 2024 06:20 GMT
… with or without ADT, after radiation therapy or surgery. Up until now … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
24 Apr 2024 02:54 GMT
… with or without ADT, after radiation therapy or surgery. Up until now … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
What Prostate Cancer Screenings Involve
23 Apr 2024 13:32 GMT
… likely to get prostate cancer.
Often, getting … says.
What Prostate Cancer Screening Involves
Prostate cancer screening typically … treatments, such as radiation therapy, surgery, chemotherapy, immunotherapy … genetic mutations for prostate cancer should be …
-
Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials
23 Apr 2024 04:01 GMT
… risk or very-high-risk prostate cancer electing to undergo radical prostatectomy … biochemical recurrence of prostate cancer after radical prostatectomy or radiation therapy.
These clinical trials … likely to be screened for prostate cancer – we have 50 sites …
-
A Randomized Trial Comparing Quality of Life after LDR or HDR Prostate Brachytherapy Boost with Pelvic External Beam Radiation Therapy - Beyond the Abstract
22 Apr 2024 20:25 GMT
… Function (IIEF), and the Expanded Prostate Cancer Index Composite (EPIC) at baseline … cohort of patients with unfavorable prostate cancer, all of whom also received … Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An …
-
Brachytherapy for High Grade Prostate Cancer Induces Distinct Changes in Circulating CD4 and CD8 T Cells - Implications for Systemic Control - Beyond the Abstract
19 Apr 2024 21:17 GMT
… biomarkers for stereotactic body radiation therapy (SBRT), which may … of patients with localized prostate cancer. Oncoimmunology. 2018;7 … for high grade prostate cancer induces distinct changes in … Cytokines in Metastatic Prostate Cancer Patients De Novo …